Pages that link to "Item:Q6076490"
From MaRDI portal
The following pages link to A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490):
Displaying 6 items.
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145) (← links)
- A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes (Q2057378) (← links)
- A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome (Q5208130) (← links)
- A Bayesian adaptive design for addressing correlated late-onset outcomes in phase I/II randomized trials of drug combinations in oncology (Q5866135) (← links)
- Seamless phase I/II design for novel anticancer agents with competing disease progression (Q6627954) (← links)
- Surv-CRM-12: a Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression (Q6629418) (← links)
